{
}
The global healthcare services market is projected to grow from $8,348.44 billion in 2023 to $8,963.64 billion in 2024, driven by advancements in medical technology, an aging population, and health insurance expansion. By 2028, it is expected to reach $10,908.99 billion, with key trends including telemedicine integration and patient-centered care. Shared medical appointments are gaining traction as a cost-effective model for managing chronic conditions, enhancing patient outcomes through collaborative care.
Cigna has confirmed it is not pursuing a merger with Humana, dismissing earlier speculation. Following this announcement, Cigna's stock rose 6.5%, while Humana's shares fell 7%. Cigna plans to focus on shareholder value through share repurchases and has $5.3 billion remaining on its repurchase authorization.
Cigna has officially confirmed it is not pursuing an acquisition of Humana, despite earlier merger talk rumors. The company plans to focus on stock buybacks, having completed $6 billion this year, and indicated that any future acquisitions would need to align strategically and financially. Following the announcement, Cigna's shares rose by 6.58%, while Humana's fell by 4.25%.
Cigna Group has confirmed it will not pursue a merger with Humana Inc., despite recent discussions between the two insurers. The company emphasized its commitment to established merger and acquisition criteria, stating it will only consider deals that are strategically aligned, financially attractive, and likely to succeed.
With President Trump’s return to the White House, health insurers are experiencing stock gains, anticipating a more favorable regulatory environment for Medicare Advantage (MA) and potential mergers. While CVS Health, Humana, and UnitedHealth Group see significant stock increases, concerns loom over Medicaid funding cuts and the future of Affordable Care Act subsidies, impacting companies like Centene and Oscar Health. Critics argue that MA plans can impose harsh restrictions, while supporters claim they offer superior care compared to traditional Medicare.
Elevance Health has filed a lawsuit against the Department of Health and Human Services over its Medicare Advantage star ratings, seeking to have its 3.75 score adjusted to a 4-star rating. The insurer claims that the current rating system, influenced by statistical variances and a single secret shopper call, has cost it $375 million and negatively impacted member benefits. Elevance, which operates in 22 states and Puerto Rico, previously succeeded in a similar lawsuit regarding the 2024 ratings.
Medicare-focused health insurers experienced significant stock gains following the expectation of increased payments from a second Trump administration. UnitedHealth Group Inc. shares surged by 7.9%, while Humana Inc. saw a rise of 10%, and CVS Health Corp. increased by 7.2%.
Insurers are advocating for improvements to Medicare Advantage (MA) as they face challenges from recent payment cuts and increasing deductibles. With open enrollment underway, companies like Humana and Elevance Health are adjusting benefits, leading to concerns about access and affordability for millions of beneficiaries. Lobbying efforts are intensifying, with significant contributions to both Republican and Democratic candidates as the 2024 election approaches.
New York City has ended coverage for GLP-1 weight-loss drugs, citing an error in their inclusion, while continuing to cover them for diabetes. Meanwhile, Michigan has filed a lawsuit against PBMs Optum Rx and Express Scripts for alleged collusion with opioid manufacturers, seeking accountability for their role in the opioid crisis. Additionally, health plans are previewing their Medicare Advantage offerings for 2025, with various expansions and new benefits aimed at diverse populations.
Consumer dissatisfaction with healthcare access is rising, with 1 in 4 feeling they lack high-quality care and many skipping necessary treatments due to costs. Innovative organizations are responding by forming cross-industry collaborations to meet evolving consumer needs, driven by a shift towards virtual health and direct-to-consumer sales. As traditional models face disruption, the market is poised for significant changes in 2025, emphasizing the importance of adapting to consumer preferences.
Humana Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
global healthcare services market poised for significant growth through 2028
United States Dollar
Community Health Systems, Inc.
UnitedHealth Group Incorporated
CVS Health Corporation
Regeneron Pharmaceuticals, Inc.
Cardinal Health, Inc.
Fresenius Medical Care AG & Co. KGaA
Centene Corporation
Baxter International Inc.
Mayo Clinic
Agilent Technologies, Inc.
Johnson & Johnson
Pfizer Inc.
Cleveland Clinic Global Solutions LLC
McKesson Corporation
Merck & Co., Inc.
Abbott Laboratories
Bristol-Myers Squibb Company
Quest Diagnostics Incorporated
HCA Healthcare, Inc.
Gilead Sciences, Inc.
Kaiser Permanente Group Trust
Cigna Corporation
Stryker Corporation
Tenet Healthcare Corporation
Danaher Corporation
AbbVie Inc.
Boston Scientific Corporation
Molina Healthcare, Inc.
Align Technology, Inc.
AmerisourceBergen Corporation
Laboratory Corporation OF America Holdings
DaVita Inc.
Eli Lilly and Company
Humana Inc.
West Pharmaceutical Services, Inc.
Fresenius Medical Care AG & Co. KGaA
Kaiser Permanente
UnitedHealth Group Incorporated
Tenet Healthcare
HCA Healthcare
Show more
20:40 11.11.2024
Cigna denies merger talks with Humana amid stock market reactions
17:22 11.11.2024
cigna confirms it will not pursue acquisition of humana
17:00 11.11.2024
cigna rules out merger talks with humana amid strategic focus
13:36 11.11.2024
insurers brace for regulatory shifts under trump administration impacting healthcare landscape
United States Dollar
Humana Inc.
UnitedHealth Group Incorporated
Cigna Corporation
Amedisys, Inc.
CVS Health Corporation
USA
J.D. Vance
Lina Khan
Joe Biden
Show more
19:07 06.11.2024
elevance health files lawsuit over medicare advantage star ratings dispute
WellPoint
Centene Corporation
Humana Inc.
UnitedHealthCare of Alabama Inc.
Elevance Health, Inc.
USA
Donald Trump
Gail Boudreaux
Joe Biden
Show more
17:28 06.11.2024
medicare health insurers surge following trump election victory
United States Dollar
UnitedHealth Group Incorporated
Humana Inc.
CVS Health Corporation
USA
Show more
13:10 06.11.2024
insurers lobby for medicare advantage reforms amid rising costs and market changes
Humana Inc.
UnitedHealthCare of Alabama Inc.
Blue Cross Blue Shield Association
Aetna Better Health Inc.
Better Medicare Alliance
USA
David Merritt
Kevin Hern
Angie Craig
Rebecca Buck
Jim Rechtin
Show more
08:00 31.10.2024
health plans adjust coverage amid lawsuits and new legislative measures
United States Dollar
HealthSherpa
Elevance Health, Inc.
Claimable
Express Scripts Holding Company
Calm Health
Devoted Health
Wellcare
Blue Cross Blue Shield of Texas
Premera Blue Cross Corporation
Molina Healthcare, Inc.
Ambetter Health
SCAN Health Plan
Humana Inc.
MVP Health Care
UnitedHealthCare of Alabama Inc.
MD Anderson Cancer Center
Essence Healthcare
Alignment Healthcare, Inc.
Aetna Better Health Inc.
Sonder Health
Optum Rx
University of Vermont Health Network
Cigna Corporation
DEU
USA
Dana Nessel
Kathy Hochul
David Ko
Show more
21:38 30.10.2024
bridging gaps in care through consumer-driven innovation in health care
DexCom, Inc.
Humana Inc.
Pfizer Inc.
Eli Lilly and Company
Best Buy Co., Inc.
USA
Brian Rush
Kulleni Gebreyes
Neal Batra
Chris Kottenstette
Show more
15:54 30.10.2024
Trending
Subcategory
Corporate News
Industry Trends
Stock Market Updates
Retail and Consumer Goods
Finance Mergers & Acquisitions
Global Financial Events
Global Trade Developments
Industry Mergers & Acquisitions
Banking Regulations
Market Analysis and Predictions
CEO Changes
Central Bank Actions
Supply Chain Management
Workplace Trends
Government Economic Policies
Startups & Entrepreneurship
Hedge Funds & Private Equity
Energy Sector Developments
Financial Scams and Security
Government Policies
Countries:
Companies:
Barclays PLC
Tesla, Inc.
BNP Paribas SA
Deutsche Bank RV Global PP
Apple Inc.
Citigroup Inc.
Raiffeisen Bank International AG
Bank of America Corporation
JPMorgan Chase & Co.
Wells Fargo & Company
UniCredit S.p.A.
The Goldman Sachs Group, Inc.
UBS Group AG
Alphabet Inc.
Strabag SE
Commerzbank AG
NVIDIA Corporation
Morgan Stanley
Lloyds Banking Group plc
Google Inc.
Currencies:
United States Dollar
Euro
Chinese Yuan
British Pound Sterling
Swiss Franc
Indian Rupee
Japanese Yen
Vietnamese Đồng
Russian Ruble
Canadian Dollar
Hong Kong Dollar
United Arab Emirates Dirham
Australian Dollar
Indonesian Rupiah
Brazilian Real
South Korean Won
Filipino Peso
Malaysian Ringgit
South African Rand
Offshore Chinese Yuan
People: